{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:57:14Z","timestamp":1792061834168,"version":"4.4.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.4155\/bio.11.27","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T17:53:29Z","timestamp":1300470809000},"page":"597-603","source":"Crossref","is-referenced-by-count":17,"title":["Regulatory Considerations for Development of Bioanalytical Assays for Biotechnology Products"],"prefix":"10.1080","volume":"3","author":[{"given":"Patrick G","family":"Swann","sequence":"first","affiliation":[{"name":"Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drugs Evaluation & Research, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie A","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drugs Evaluation & Research, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,3,18]]},"reference":[{"key":"e_1_3_4_3_1_1","unstructured":"Ligand Binding Assays: Development Validation and Implementation in the Drug Development Arena. Khan MN Findlay JWA (Eds). John Wiley & Sons NY USA (2010)."},{"key":"e_1_3_4_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1108-1227"},{"key":"e_1_3_4_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3229"},{"key":"e_1_3_4_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2747"},{"key":"e_1_3_4_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03638-X"},{"key":"e_1_3_4_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.170"},{"key":"e_1_3_4_3_7_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.108.1.195"},{"key":"e_1_3_4_3_8_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.10.64"},{"key":"e_1_3_4_3_9_1","doi-asserted-by":"publisher","DOI":"10.3233\/HAB-2009-0206"},{"key":"e_1_3_4_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2009.05.030"},{"key":"e_1_3_4_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.04.006"},{"key":"e_1_3_4_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.04.031"},{"key":"e_1_3_4_3_13_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.3.11788"},{"key":"e_1_3_4_3_14_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.6.13333"},{"key":"e_1_3_4_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011931"},{"key":"e_1_3_4_3_16_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.6.13601"},{"key":"e_1_3_4_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_3_4_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0183-7"},{"key":"e_1_3_4_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32832a06bf"},{"key":"e_1_3_4_3_20_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000003390.51761.3d"},{"key":"e_1_3_4_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9291-7"},{"key":"e_1_3_4_3_22_1","first-page":"28526","article-title":"US FDA. Guidance for Industry: Bioanalytical Method Validation; Availability. [Docket No. 98D\u20131195]","volume":"66","year":"2001","unstructured":"US FDA. Guidance for Industry: Bioanalytical Method Validation; Availability. [Docket No. 98D\u20131195]. Federal Register66, 28526\u201328527 (2001).","journal-title":"Federal Register"},{"key":"e_1_3_4_3_23_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj0902016"},{"key":"e_1_3_4_3_24_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9047-2"},{"key":"e_1_3_4_3_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804787200"},{"key":"e_1_3_4_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwn120"},{"key":"e_1_3_4_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2009.09.027"},{"key":"e_1_3_4_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.06.011"},{"key":"e_1_3_4_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03647.x"},{"key":"e_1_3_4_3_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3234"},{"key":"e_1_3_4_3_31_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.7467"},{"key":"e_1_3_4_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.08.022"},{"key":"e_1_3_4_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2010.11.011"},{"key":"e_1_3_4_3_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1439758"},{"key":"e_1_3_4_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.07.001"},{"key":"e_1_3_4_3_36_1","doi-asserted-by":"publisher","DOI":"10.1039\/b814398f"},{"key":"e_1_3_4_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-009-3041-0"},{"key":"e_1_3_4_3_38_1","doi-asserted-by":"publisher","DOI":"10.1039\/b819706g"},{"key":"e_1_3_4_3_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac800205s"},{"key":"e_1_3_4_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.06.002"},{"key":"e_1_3_4_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2006.12.004"},{"key":"e_1_3_4_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2008.01.001"},{"key":"e_1_3_4_3_43_1","first-page":"63758","article-title":"US FDA, Draft Guidance for Industry on Assay Development for Immunogenicity Testing of Therapeutic Proteins; Availability. [Docket No. FDA-2009-D-0539]","volume":"74","year":"2009","unstructured":"US FDA, Draft Guidance for Industry on Assay Development for Immunogenicity Testing of Therapeutic Proteins; Availability. [Docket No. FDA-2009-D-0539]. Federal Register74, 63758 (2009).","journal-title":"Federal Register"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio.11.27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:56:36Z","timestamp":1715943396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio.11.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.4155\/bio.11.27"],"URL":"https:\/\/doi.org\/10.4155\/bio.11.27","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}